The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEveryman Media Regulatory News (EMAN)

Share Price Information for Everyman Media (EMAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.50
Bid: 57.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.754%)
Open: 57.50
High: 57.50
Low: 57.50
Prev. Close: 57.50
EMAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Jul 2022 07:00

RNS Number : 8388T
Everyman Media Group PLC
27 July 2022
 

27 July 2022

 

Everyman Media Group PLC

("Everyman" the "Company" or the "Group")

 

Trading Update

 

Everyman Media Group plc (AIM: EMAN) provides the following trading update for the 26 weeks ending 30 June 2022.

 

Group revenue of £40.7m, an increase of £11.8m vs. the same period in 2019.

Group EBITDA1 of £7.5m, an increase of £0.9m vs. the same period in 2019.

 

The Group's performance was particularly reassuring given that 2019 was a record year. Growth was driven by a combination of an increased number of venues, strong admissions and higher average spends as well as benefitting from reduced VAT in the first quarter. The Board is confident the financial performance of the Company for the full year ending 31 December 2022 will be in line with market expectations.

 

The Group ended the period operating 37 cinemas (H1 2019: 28 cinemas), having opened a five-screen venue in Edinburgh.

 

The Board is also pleased to announce the pipeline for H2 2022 and 2023 is well progressed with a minimum of six further venues contracted to open.

 

The Group intends to publish its interim results for the 26 weeks ended 30 June 2022 on 28 September 2022.

 

Alex Scrimgeour, Chief Executive Officer of Everyman Media Group PLC, said:

"It has been a busy six months for the Group, as our exceptional venue teams entertained guests across the country. Despite well publicised headwinds we have managed to deliver record half year sales and EBITDA. We remain confident that people's enjoyment of cinema and specifically Everyman remains undiminished".

 

(1) Adjusted for pre-opening costs, acquisition expenses, depreciation, amortisation, share based payments and costs incurred directly related to Covid-19. IFRS 16 has been applied.

 

For further information, please contact:

 

Everyman Media Group PLC

Alex Scrimgeour, Chief Executive

Tel: +44 (0)20 3145 0500

Will Worsdell, Finance Director

Canaccord Genuity Limited (Nominated Adviser and Broker)

Tel: +44 (0)20 7523 8000

Bobbie Hilliam

Georgina McCooke

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0205

Susie Hudson

David Ison

Joe Pederzolli

 

About Everyman Media Group PLC:

 

Everyman is the fourth largest cinema business in the UK by number of venues, and is a premium, high growth leisure brand. Everyman operates a growing estate of venues across the UK, with an emphasis on providing first class cinema and hospitality.

 

Everyman is redefining cinema. It focuses on venue and experience as key competitive strengths, with a unique proposition:

 

· Intimate and atmospheric venues, which become a destination in their own right

· An emphasis on a strong quality food and drink menu prepared in-house

· A broad range of well-curated programming content, from mainstream and independent films to theatre and live concert streams, appealing to a diverse range of audiences

· Motivated and welcoming teams

 

For more information visit http://investors.everymancinema.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKABBDBKBBOB
Date   Source Headline
18th Apr 20249:17 amRNSDirector/PDMR Shareholding
17th Apr 20247:00 amRNSGrant of Options
16th Apr 20247:00 amRNSFinal Results to 28 December 2023
28th Mar 20247:00 amRNSNotice of Results and Investor Presentation
9th Feb 202412:45 pmRNSCorrection: Director/PDMR Shareholding
2nd Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSTrading Update
15th Dec 20237:00 amRNSAcquisition
23rd Nov 202311:19 amRNSDirector/PDMR Shareholding
22nd Nov 20231:36 pmRNSDirector/PDMR Shareholding
20th Oct 20237:00 amRNSDirector/PDMR Shareholding
3rd Oct 20237:00 amRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSInterim Results
18th Aug 20232:20 pmRNSDirector/PDMR Shareholding
18th Aug 202312:00 pmRNSGrant of Options and Changes to Option Terms
18th Aug 20237:01 amRNSNew banking facilities
18th Aug 20237:00 amRNSTrading Update and Notice of Results
15th Jun 20234:41 pmRNSResults of Annual General Meeting
10th May 20231:30 pmRNSHolding(s) in Company
5th May 20231:45 pmRNSHolding(s) in Company
4th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFinal Results to 29 December 2022
24th Mar 20237:00 amRNSNotice of Results
1st Feb 20235:11 pmRNSGrant of Options
25th Jan 20234:56 pmRNSDirector/PDMR Shareholding
23rd Jan 20239:00 amRNSDirector/PDMR Shareholding
23rd Jan 20237:00 amRNSTrading Update
8th Dec 20227:39 amRNSHolding(s) in Company
18th Nov 20227:00 amRNSDirectorate Change
25th Oct 20227:00 amRNSGrant of Options
28th Sep 20227:00 amRNSInterim Results
20th Sep 20227:00 amRNSDirector Appointment
11th Aug 20227:00 amRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSHolding(s) in Company
27th Jul 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:01 amRNSDirectorate Change
28th Jun 20227:00 amRNSDirectorate Change
17th Jun 20227:00 amRNSDirector/PDMR Shareholding
16th May 20225:30 pmRNSPosting of Annual Report and Notice of AGM
31st Mar 20227:00 amRNSDirectorate Change
25th Mar 20227:00 amRNSFinal Results to 30 December 2021
31st Jan 20228:31 amRNSTotal Voting Rights
21st Jan 20227:00 amRNSTrading Update
20th Jan 20225:15 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.